LAVA Therapeutics N.V.

LAVA Therapeutics N.V.verified

LVTX

Price:

$0.9752

Market Cap:

$25.64M

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia; and LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is also developing other Gammabody...[Read more]

Industry

Biotechnology

IPO Date

2021-03-26

Stock Exchange

NASDAQ

Ticker

LVTX

The Current Ratio as of December 2024 (TTM) for LAVA Therapeutics N.V. (LVTX) is 5.36

According to LAVA Therapeutics N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 5.36. This represents a change of -16.81% compared to the average of 6.45 of the last 4 quarters.

LAVA Therapeutics N.V. (LVTX) Historical Current Ratio (quarterly & annually)

How has LVTX Current Ratio performed in the past?

The mean historical Current Ratio of LAVA Therapeutics N.V. over the last ten years is 10.34. The current 5.36 Current Ratio has changed 5.09% with respect to the historical average. Over the past ten years (40 quarters), LVTX's Current Ratio was at its highest in in the December 2021 quarter at 30.80. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

10.34

Median

6.40

Minimum

2.54

Maximum

30.80

LAVA Therapeutics N.V. (LVTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of LAVA Therapeutics N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.11%

Maximum Annual Current Ratio = 30.80

Minimum Annual Increase = -79.22%

Minimum Annual Current Ratio = 2.54

Quarterly (TTM)
Annual
YearCurrent RatioChange
20236.623.40%
20226.40-79.22%
202130.801.11%
20202.54-52.51%

LAVA Therapeutics N.V. (LVTX) Average Current Ratio

How has LVTX Current Ratio performed in the past?

The current Current Ratio of LAVA Therapeutics N.V. (LVTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.61

5-year avg

10.34

10-year avg

10.34

LAVA Therapeutics N.V. (LVTX) Current Ratio vs. Peers

How is LVTX’s Current Ratio compared to its peers?

LAVA Therapeutics N.V.’s Current Ratio is greater than Anebulo Pharmaceuticals, Inc. (3.45), less than PMV Pharmaceuticals, Inc. (13.98), greater than Miromatrix Medical Inc. (3.46), greater than ZIVO Bioscience, Inc. (0.17), greater than Bionomics Limited (3.30), less than Edgewise Therapeutics, Inc. (26.35), less than Ikena Oncology, Inc. (15.32), less than Design Therapeutics, Inc. (34.61), greater than Xilio Therapeutics, Inc. (1.67), less than Eliem Therapeutics, Inc. (0), less than Aerovate Therapeutics, Inc. (8.78), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than Rezolute, Inc. (13.79), less than AN2 Therapeutics, Inc. (9.75), less than Generation Bio Co. (6.34), less than Kronos Bio, Inc. (8.32), less than Erasca, Inc. (11.00), less than C4 Therapeutics, Inc. (6.31), less than Neoleukin Therapeutics, Inc. (15.33), less than Instil Bio, Inc. (12.90), less than Achilles Therapeutics plc (6.04), less than NextCure, Inc. (9.07), greater than Assembly Biosciences, Inc. (2.36),

Build a custom stock screener for LAVA Therapeutics N.V. (LVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LAVA Therapeutics N.V. (LVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LAVA Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is LAVA Therapeutics N.V.'s Current Ratio?

How is the Current Ratio calculated for LAVA Therapeutics N.V. (LVTX)?

What is the highest Current Ratio for LAVA Therapeutics N.V. (LVTX)?

What is the 3-year average Current Ratio for LAVA Therapeutics N.V. (LVTX)?

What is the 5-year average Current Ratio for LAVA Therapeutics N.V. (LVTX)?

How does the current Current Ratio for LAVA Therapeutics N.V. (LVTX) compare to its historical average?